KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Guardant Health (GH) Current Assets: 2017-2025

Historic Current Assets for Guardant Health (GH) over the last 7 years, with Sep 2025 value amounting to $828.9 million.

  • Guardant Health's Current Assets fell 32.43% to $828.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was $828.9 million, marking a year-over-year decrease of 32.43%. This contributed to the annual value of $1.1 billion for FY2024, which is 21.68% down from last year.
  • Guardant Health's Current Assets amounted to $828.9 million in Q3 2025, which was down 6.17% from $883.4 million recorded in Q2 2025.
  • Guardant Health's 5-year Current Assets high stood at $2.0 billion for Q1 2021, and its period low was $828.9 million during Q3 2025.
  • In the last 3 years, Guardant Health's Current Assets had a median value of $1.2 billion in 2024 and averaged $1.2 billion.
  • As far as peak fluctuations go, Guardant Health's Current Assets surged by 234.72% in 2021, and later crashed by 45.24% in 2022.
  • Quarterly analysis of 5 years shows Guardant Health's Current Assets stood at $1.1 billion in 2021, then climbed by 6.95% to $1.2 billion in 2022, then climbed by 13.05% to $1.3 billion in 2023, then fell by 21.68% to $1.1 billion in 2024, then tumbled by 32.43% to $828.9 million in 2025.
  • Its Current Assets stands at $828.9 million for Q3 2025, versus $883.4 million for Q2 2025 and $927.0 million for Q1 2025.